Lumiracoxib is a potent,selective and orally active COX-2 inhibitor with a Ki value of 0.06 µM[1]. Lumiracoxib acts as a nonselective NSAID with anti-inflammatory, analgesic and antipyretic activities. Lumiracoxib can be used for osteoarthritis and bone cancer research[1][2].
Molecular Weight:
293.72
Purity:
99.93
CAS Number:
[220991-20-8]
Formula:
C15H13ClFNO2
Target:
COX
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted